<DOC>
	<DOCNO>NCT00006503</DOCNO>
	<brief_summary>To evaluate subclinical atherosclerotic disease menopausal woman .</brief_summary>
	<brief_title>Prevalence &amp; Progression Subclinical Atherosclerosis</brief_title>
	<detailed_description>BACKGROUND : Decreased ovarian function premenopausal obesity likely primary determinant early coronary atherosclerosis measure calcification EBCT . Aortic calcification occur early coronary calcification , may predict coronary calcification , expect best marker risk associate traditional factor young woman . Preliminary data indicate change coronary aortic calcification observe short period time woman . A period diminish estrogen level optimum time observe change endothelial function likely precede measurable atherosclerosis thus may earliest marker disease potential . Vascular stiffness , marker biologic age vascular system , highly correlated measure insulin sensitivity alter woman mid-life conjunction increase central adiposity . Racial difference disease prevalence relative importance certain risk factor likely . DESIGN NARRATIVE : Subclinical atherosclerosis evaluate 728 woman ( 305 African American , 423 Caucasian ) enrol Pittsburgh Chicago sit Study Women 's Health Across Nation ( SWAN ) , multicenter study characterize biological psychosocial antecedent sequellae menopause . The extent diminish ovarian function affect vascular function accelerate development atherosclerosis coronary artery , aorta carotid artery evaluate . Serial measure coronary aortic calcification ( electron beam compute tomography [ EBCT ] ) , carotid atherosclerosis , endothelial function aortic stiffening perform two year apart . The prevalence progression subclinical atherosclerosis evaluate relation serial measure ovarian function , psychosocial behavioral factor , marker clot inflammation well traditional cardiovascular risk factor , collect SWAN . The study conduct jointly Dr. Lynda Powell ( R01HL65581 ) Rush-Presbyterian-St. Luke 's Medical Center Chicago Dr. Kim Tyrrell ( R01HL65591 ) University Pittsburgh .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>